Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1691.41
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 01-Sep-2026
NAV [Rs.]
: 27.5538
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.86 | 1 | 10.92 | 16.99 | 23.46 | 21.77 | 13.89 | 13.38 |
| Category Avg | -1.15 | 0.41 | 3.16 | 0.96 | 11.76 | 14.66 | 10.72 | 11.48 |
| Category Best | 2.36 | 7.55 | 21.46 | 33.61 | 86.29 | 44.18 | 29.88 | 121.77 |
| Category Worst | -4.5 | -5.97 | -12.4 | -22.79 | -17.16 | -1.83 | 0.18 | -21.72 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
Sai Life2,35,741
Out
InName Of The CompanyNo Of Shares
J B Chemicals &1,43,450
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 21.29 | 1809360 | 360.15 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 10.34 | 217175 | 174.95 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 8.37 | 961503 | 141.64 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 7.59 | 250628 | 128.39 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 7.14 | 664858 | 120.75 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 7.07 | 1041627 | 119.58 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.93 | 414984 | 100.21 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.42 | 472990 | 74.74 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.40 | 99992 | 57.51 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.40 | 257291 | 57.47 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.07 | 1219138 | 51.89 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.85 | 427497 | 48.17 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.82 | 193472 | 47.77 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.45 | 237346 | 41.48 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.02 | 136179 | 34.08 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 1.83 | 235741 | 31.00 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.63 | 141116 | 27.65 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.47 | 71915 | 24.92 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.46 | 8906 | 24.75 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.23 | 1062797 | 20.78 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,67,506.41
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
